October 18, 2017 12:22 AM ET

Biotechnology

Company Overview of Valor Biotherapeutics, LLC

Key Executives for Valor Biotherapeutics, LLC

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

Valor Biotherapeutics, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
David Shanahan 11 RelationshipsGradalis, Inc.--
Sanjay D. Khare Ph.D. 10 RelationshipsImmunGene Inc.--
Michael J. Gresser Ph.D. 47 RelationshipsImmunGene Inc.--
View All Board Members

Valor Biotherapeutics, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
388.0K
Bonus
241.5K
Total Short Term Compensation
483.3K
Total Value of Options
17.8M
Compensation as of Fiscal Year
Valor Biotherapeutics, LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Silicon Therapeutics Appoints Dr. Christopher Winter as Chief of R&D
October 16, 2017 4:30 PM ET
Boston Biomedical, Inc. Appoints Edgar Braendle, M.D., Ph.D., as Head of Research and Development and Chief Medical Officer
October 16, 2017 3:50 PM ET
Azurrx Biopharma, Inc. Announces Appointment of Vern Lee Schramm to the Board of Directors
October 16, 2017 12:30 PM ET
INmune Bio, Inc. Appoints Edgardo Baracchini to the Board of Directors
October 16, 2017 12:30 PM ET
Silence Therapeutics plc Appoints Annalisa Jenkins as Non-Executive Chair of Board of Directors
October 16, 2017 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Valor Biotherapeutics, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.